Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | GRM7 | Q14831 | 1/20 | 0.32 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.32 |
| ▸ | BRD4 | O60885 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Flumioxazin SCHEMBL7589902 | 0.94 | GRM7 (0.34) | TP53MAPTMEN1KMT2AGRM7 | |
| Flumioxazin SCHEMBL7581161 | 0.88 | TSHR (0.39) | MEN1KMT2AGRM7GRM4BRD4 | |
| Flumioxazin SCHEMBL7579042 | 0.86 | GRM7 (0.36) | GRM7GRM4 | |
| Flumipropyn SCHEMBL7578798 | 0.84 | GRM7 (0.34) | GRM7GRM4BRD4 | |
| Flumioxazin SCHEMBL7579276 | 0.84 | GRM4 (0.32) | TP53MAPTMEN1KMT2AGRM7 | |
| Clomazone SCHEMBL7579542 | 0.83 | TP53 (0.31) | TP53MAPT | |
| Flumioxazin SCHEMBL7584341 | 0.81 | GRM7 (0.33) | GRM7GRM4 | |
| Flumioxazin SCHEMBL7587064 | 0.80 | GRM7 (0.33) | GRM7GRM4 | |
| Flumiciorac-Pentyl SCHEMBL7579959 | 0.79 | PPOX (0.34) | GRM7GRM4BRD4 | |
| Flumioxazin SCHEMBL7578756 | 0.79 | TP53 (0.35) | TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020004457-A1 | Herbicidal composition | SYNGENTA PARTICIPATIONS AG (CH) | 2002-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020004457-A1 | Herbicidal composition | PPOX, ALAD, DDT | TP53 4303/4885MAPT 1092/4885MEN1 4274/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.